Medicare Advantage & Prescription Drug Program Audit Process Center for Medicare Medicare Part C & Part D Oversight and Enforcement Group
Guidance for CMS annual updating of the program audits of Prescription Drug Plan (PDP) and Medicare Advantage Organization (MAO) Sponsoring Organizations
(SO)1 who enter into contracts based on comments received from the industry via email, conference events, industry listening sessions, and the post audit questionnaire distributed at the conclusion of each audit.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 01, 2014
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.